Viewing Study NCT00267592


Ignite Creation Date: 2025-12-24 @ 3:55 PM
Ignite Modification Date: 2026-01-03 @ 7:46 AM
Study NCT ID: NCT00267592
Status: COMPLETED
Last Update Posted: 2016-05-19
First Post: 2005-12-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Talampanel in Glioblastoma Multiforme
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module